Cagdas Yilmaz has been appointed the Europe Middle East and Africa (EMEA) Integrated Brand Value Team Leader of Johnson&Johnson’s pharmaceutical company, Janssen Turkey. Prior to his new position, Yilmaz worked as Oncology and Hematology Business Unit Director for the company. In his new position, Yilmaz will be responsible for the implementation and management of commercial strategies and tactics for the EMEA region for cell therapies. Cagdas Yilmaz, who will also lead the Integrated Brand Value Team, will guide launch preparations across functions and EMEA in the new period. Yilmaz, who has 20 years of professional experience, has worked in different positions since 2013 at Johnson&Johnson.
Latest News:
The message from Russia: ‘I am in the Middle East too’
What matters on Thursday, March 23
The post-earthquake needs analysis
What matters on Wednesday, March 22
World automotive sector influenced by semiconductors (chip sector) demand
The highest monthly CAD in the history of the republic
What matters on Tuesday, March 21
What matters on Monday, March 20
Dollar lost its savings instrument edge
Quake-hit cities to get investment support
15% of earthquake victim voters migrated
What matters on Tuesday, March 14
A law specific to Istanbul is a must: Mayor of Istanbul
Share of compensation of employees in the GVA hits a 25-year low
Hunger limit doesn’t fit in wallets; new banknote is needed
Opposition bloc eyes deal to reunite, elevate popular mayors
Central Bank and SFD ink USD 5bn deposit deal
What matters on Monday, March 6
A big slowdown in the rate of interest reduction!
Turkey at a Glance
YILMAZ BECOMES EMEA INTEGRATED BRAND VALUE TEAM LEADER OF JANSSEN TURKEY
August 9, 2021August 2, 2021

Leave a Reply